本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Nurix Therapeutics

11.61
+0.15001.31%
盘后11.610.00000.00%16:20 EDT
成交量:250.47万
成交额:2,962.74万
市值:8.85亿
市盈率:-4.14
高:12.38
开:11.97
低:11.55
收:11.46
数据加载中...
2025/04/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/08

重要事件披露

Form 8-K - Current report
2025/03/14

SEC问询函

Form CORRESP - Correspondence
2025/03/13

重要事件披露

Form 8-K - Current report
2025/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/01/28

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/10

重要事件披露

Form 8-K - Current report
2024/12/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities